Amino Acid [EPC]

Amino Acid [EPC] was reported 60361 times

Drugs of the Amino Acid [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE 50 0.5618
1 SICKLE CELL DISEASE 58 0.1255
2 SICKLE CELL ANAEMIA WITH CRISIS 1783 0.1130
3 CEREBRAL MICROEMBOLISM 2 0.0909
4 ACUTE CHEST SYNDROME 72 0.0819
5 EMERGENCY CARE 129 0.0425
6 TENDON CALCIFICATION 7 0.0395
7 APNOEA NEONATAL 9 0.0347
8 BONE CALLUS EXCESSIVE 2 0.0250
9 CAPILLARY NAIL REFILL TEST ABNORMAL 2 0.0192
10 CATHETER SEPSIS 4 0.0191
11 BLOOD CHLORIDE ABNORMAL 3 0.0185
12 SICKLE CELL ANAEMIA 11 0.0171
13 TOXIC ERYTHEMA OF CHEMOTHERAPY 3 0.0116
14 GENERALISED PUSTULAR PSORIASIS 3 0.0103
15 FEEDING DISORDER NEONATAL 9 0.0086
16 FUNGAL SEPSIS 7 0.0084
17 PRODUCT COMPOUNDING QUALITY ISSUE 3 0.0082
18 SPLENIC LESION 3 0.0081
19 CHOLESTEATOMA 2 0.0072
20 ADMINISTRATION SITE ERYTHEMA 2 0.0070
21 ADNEXA UTERI MASS 2 0.0069
22 BENIGN OVARIAN TUMOUR 2 0.0063
23 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 5 0.0059
24 BLOOD MAGNESIUM INCREASED 5 0.0055
25 LIP EROSION 4 0.0055
26 ASYMPTOMATIC COVID-19 2 0.0051
27 LYMPHANGITIS 4 0.0050
28 IRON OVERLOAD 5 0.0046
29 EXTRAVASATION 19 0.0046
30 CATARACT NUCLEAR 3 0.0045
31 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 5 0.0045
32 DEVICE RELATED SEPSIS 9 0.0045
33 BONE INFARCTION 2 0.0044
34 PEPTIC ULCER HAEMORRHAGE 3 0.0043
35 SPLENECTOMY 5 0.0043
36 PRODUCT DOSE OMISSION 280 0.0043
37 ADMINISTRATION SITE EXTRAVASATION 4 0.0040
38 BLOOD FIBRINOGEN INCREASED 3 0.0038
39 TRANSFUSION REACTION 3 0.0034
40 INTENTIONAL UNDERDOSE 25 0.0034
41 MUCOSAL EROSION 3 0.0033
42 FUNGAEMIA 5 0.0032
43 ASPERGILLOSIS 4 0.0031
44 DACTYLITIS 3 0.0031
45 GASTRIC PH DECREASED 3 0.0029
46 VASCULAR CALCIFICATION 3 0.0028
47 FOETAL GROWTH RESTRICTION 17 0.0028
48 BITE 2 0.0028
49 TUMOUR PSEUDOPROGRESSION 3 0.0027
50 COMA HEPATIC 2 0.0027
51 CARBOHYDRATE ANTIGEN 125 INCREASED 9 0.0026
52 PRODUCT DOSE OMISSION ISSUE 759 0.0026
53 INCISION SITE PAIN 3 0.0026
54 FULL BLOOD COUNT INCREASED 3 0.0025
55 BRONCHOPULMONARY DYSPLASIA 2 0.0025
56 ORAL MUCOSA EROSION 3 0.0024
57 CARDIAC STRESS TEST ABNORMAL 2 0.0024
58 BLOOD PARATHYROID HORMONE INCREASED 7 0.0024
59 TRANSFUSION 25 0.0024
60 DEAFNESS TRANSITORY 2 0.0023
61 SENSITIVITY OF TEETH 4 0.0023
62 ABSCESS DRAINAGE 2 0.0023
63 HIRSUTISM 3 0.0023
64 MACULAR HOLE 3 0.0022
65 GLYCOSURIA 3 0.0022
66 CERUMEN IMPACTION 2 0.0022
67 BILIRUBIN CONJUGATED INCREASED 5 0.0021
68 POST HERPETIC NEURALGIA 3 0.0021
69 BONE SWELLING 2 0.0021
70 NAIL DISCOLOURATION 8 0.0020
71 CATHETER RELATED INFECTION 2 0.0020
72 NEOPLASM SKIN 3 0.0019
73 ELECTROCARDIOGRAM T WAVE ABNORMAL 3 0.0019
74 BODY TEMPERATURE FLUCTUATION 4 0.0019
75 LOOSE TOOTH 6 0.0019
76 HYPERNATRAEMIA 9 0.0018
77 VEIN RUPTURE 3 0.0018
78 INFECTIOUS MONONUCLEOSIS 4 0.0018
79 CERVICAL SPINAL STENOSIS 3 0.0017
80 EMOTIONAL POVERTY 3 0.0017
81 HAEMATOLOGICAL INFECTION 4 0.0016
82 BLOOD IRON INCREASED 3 0.0016
83 SYSTEMIC CANDIDA 4 0.0016
84 BONE MARROW TRANSPLANT 3 0.0016
85 ADNEXA UTERI PAIN 2 0.0016
86 HEPATIC MASS 3 0.0016
87 TREATMENT NONCOMPLIANCE 84 0.0015
88 APLASIA 3 0.0015
89 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
90 JOINT CREPITATION 3 0.0015
91 INSURANCE ISSUE 23 0.0015
92 PRODUCT USE COMPLAINT 23 0.0015
93 HOSPITALISATION 222 0.0014
94 MACULE 4 0.0014
95 CHOLECYSTITIS INFECTIVE 4 0.0014
96 STAPHYLOCOCCAL SEPSIS 7 0.0014
97 BONE LESION 5 0.0014
98 APRAXIA 2 0.0013
99 SKIN NECROSIS 7 0.0013
100 THERAPY CESSATION 69 0.0013
101 PRODUCT DOSE OMISSION IN ERROR 38 0.0013
102 BLOOD LOSS ANAEMIA 3 0.0013
103 PRE-EXISTING CONDITION IMPROVED 8 0.0013
104 UNDERDOSE 93 0.0013
105 ABDOMINAL ADHESIONS 4 0.0013
106 SKIN FRAGILITY 3 0.0012
107 ANAPHYLACTOID REACTION 5 0.0012
108 ENTEROCOLITIS 7 0.0012
109 VENOOCCLUSIVE DISEASE 3 0.0012
110 CHOLESTASIS 23 0.0012
111 HYPERPARATHYROIDISM SECONDARY 3 0.0012
112 EXCORIATION 3 0.0012
113 PATHOLOGICAL FRACTURE 6 0.0012
114 HYPERPYREXIA 5 0.0012
115 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
116 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
117 AORTIC ARTERIOSCLEROSIS 3 0.0012
118 LYMPHOEDEMA 8 0.0012
119 HEPATIC LESION 5 0.0012
120 ACTINIC KERATOSIS 3 0.0012
121 OCULAR ICTERUS 5 0.0012
122 ALOPECIA AREATA 2 0.0011
123 GASTROINTESTINAL STROMAL TUMOUR 3 0.0011
124 ANIMAL BITE 3 0.0011
125 SHOULDER ARTHROPLASTY 3 0.0011
126 HIP SURGERY 6 0.0011
127 LIP BLISTER 3 0.0011
128 URINE ABNORMALITY 5 0.0011
129 POLYURIA 9 0.0011
130 THROMBOCYTOSIS 4 0.0011
131 THERAPY INTERRUPTED 78 0.0011
132 POOR QUALITY DRUG ADMINISTERED 7 0.0011
133 DENTAL CARE 2 0.0011
134 ENDOTRACHEAL INTUBATION 3 0.0011
135 ADENOCARCINOMA OF COLON 2 0.0011
136 MATERNAL EXPOSURE TIMING UNSPECIFIED 4 0.0011
137 PROTEIN TOTAL DECREASED 4 0.0011
138 JOINT LOCK 3 0.0011
139 VITAMIN B12 DECREASED 3 0.0010
140 ESCHERICHIA SEPSIS 3 0.0010
141 BILIARY COLIC 3 0.0010
142 THERAPY CHANGE 10 0.0010
143 PRODUCT AVAILABILITY ISSUE 23 0.0010
144 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
145 BLOOD CULTURE POSITIVE 3 0.0010
146 FLUID INTAKE REDUCED 5 0.0010
147 CARDIAC DISCOMFORT 2 0.0010
148 ADVERSE EVENT 91 0.0010
149 DYSAESTHESIA 3 0.0010
150 PHLEBITIS 5 0.0010
151 TENDON RUPTURE 12 0.0010
152 TEMPERATURE INTOLERANCE 10 0.0010
153 CAPILLARY LEAK SYNDROME 2 0.0010
154 BILE DUCT STONE 3 0.0009
155 HEPATIC CYTOLYSIS 12 0.0009
156 ABDOMINAL PAIN UPPER 188 0.0009
157 DEAFNESS NEUROSENSORY 3 0.0009
158 LISTLESS 3 0.0009
159 PARONYCHIA 4 0.0009
160 COLONOSCOPY 2 0.0009
161 MALNUTRITION 10 0.0009
162 DRUG DOSE OMISSION 146 0.0009
163 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
164 TACHYPNOEA 12 0.0009
165 HAEMOGLOBIN INCREASED 4 0.0009
166 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
167 HAIR GROWTH ABNORMAL 6 0.0009
168 CONSTIPATION 188 0.0009
169 DISCOURAGEMENT 2 0.0009
170 HYPERTRIGLYCERIDAEMIA 5 0.0009
171 HIP ARTHROPLASTY 13 0.0008
172 APPENDICECTOMY 3 0.0008
173 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
174 PHARYNGITIS STREPTOCOCCAL 9 0.0008
175 HUMERUS FRACTURE 4 0.0008
176 OESOPHAGITIS 9 0.0008
177 OSTEONECROSIS 27 0.0008
178 BLOOD PHOSPHORUS DECREASED 3 0.0008
179 BREATH ODOUR 2 0.0008
180 BRONCHITIS CHRONIC 2 0.0008
181 IMMUNE-MEDIATED ENTEROCOLITIS 3 0.0008
182 VENOOCCLUSIVE LIVER DISEASE 4 0.0008
183 RASH MACULO-PAPULAR 18 0.0008
184 DEVICE INFUSION ISSUE 2 0.0008
185 ABDOMINAL TENDERNESS 4 0.0008
186 DYSPHORIA 4 0.0008
187 BLOOD PRESSURE DIASTOLIC ABNORMAL 2 0.0008
188 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
189 CLAVICLE FRACTURE 3 0.0008
190 PRODUCT COLOUR ISSUE 4 0.0008
191 BLOOD CHLORIDE DECREASED 2 0.0008
192 HYPERBILIRUBINAEMIA 8 0.0008
193 CATHETER SITE PAIN 2 0.0008
194 SKIN ODOUR ABNORMAL 3 0.0008
195 BEDRIDDEN 10 0.0008
196 CORONAVIRUS INFECTION 5 0.0008
197 DYSMENORRHOEA 10 0.0008
198 AREFLEXIA 2 0.0007
199 ABDOMINAL MASS 2 0.0007
200 BREAST SWELLING 2 0.0007
201 BLOOD SODIUM DECREASED 14 0.0007
202 ANORGASMIA 2 0.0007
203 RECURRENT CANCER 3 0.0007
204 RED BLOOD CELL COUNT DECREASED 21 0.0007
205 CLUMSINESS 2 0.0007
206 GOITRE 3 0.0007
207 BLOOD PHOSPHORUS INCREASED 2 0.0007
208 GENERALISED OEDEMA 9 0.0007
209 BLOOD COUNT ABNORMAL 11 0.0007
210 BLOOD ALKALINE PHOSPHATASE INCREASED 18 0.0007
211 ATELECTASIS 7 0.0007
212 GASTROENTERITIS VIRAL 13 0.0007
213 HEART RATE ABNORMAL 4 0.0007
214 PAPULE 5 0.0007
215 CEREBRAL THROMBOSIS 2 0.0007
216 INTENTIONAL DOSE OMISSION 20 0.0007
217 ADVERSE DRUG REACTION 63 0.0007
218 CHOLECYSTECTOMY 8 0.0007
219 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
220 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
221 TONGUE DISCOLOURATION 3 0.0007
222 SPLENOMEGALY 8 0.0007
223 HYPERLIPIDAEMIA 8 0.0007
224 BACK PAIN 154 0.0007
225 VASCULAR DEVICE INFECTION 3 0.0007
226 SKIN ULCER 17 0.0007
227 BLOOD UREA INCREASED 11 0.0007
228 DISEASE COMPLICATION 3 0.0007
229 EAR DISORDER 3 0.0007
230 BOWEL MOVEMENT IRREGULARITY 5 0.0007
231 EYE OPERATION 3 0.0007
232 SMALL INTESTINAL OBSTRUCTION 8 0.0006
233 SYNOVIAL CYST 3 0.0006
234 HYPERCALCAEMIA 8 0.0006
235 NEPHROGENIC ANAEMIA 3 0.0006
236 TENDONITIS 10 0.0006
237 HYPOALBUMINAEMIA 5 0.0006
238 BLOOD CREATININE DECREASED 2 0.0006
239 MULTI-ORGAN FAILURE 11 0.0006
240 SEASONAL ALLERGY 9 0.0006
241 VIRAL UPPER RESPIRATORY TRACT INFECTION 3 0.0006
242 PNEUMOTHORAX 10 0.0006
243 FOREIGN BODY SENSATION IN EYES 4 0.0006
244 WHITE BLOOD CELL COUNT ABNORMAL 4 0.0006
245 LIMB OPERATION 3 0.0006
246 ENTERITIS 4 0.0006
247 INFUSION SITE PAIN 8 0.0006
248 INTERNAL HAEMORRHAGE 7 0.0006
249 MEDICATION ERROR 34 0.0006
250 HYPERVOLAEMIA 3 0.0006
251 ELECTROLYTE IMBALANCE 7 0.0006
252 VULVOVAGINAL PRURITUS 3 0.0006
253 DYSLIPIDAEMIA 3 0.0006
254 BACTERAEMIA 7 0.0006
255 BACTERIAL INFECTION 11 0.0006
256 B-CELL LYMPHOMA 2 0.0006
257 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 3 0.0006
258 PHOTOPHOBIA 11 0.0006
259 ABDOMINAL DISCOMFORT 98 0.0006
260 ECCHYMOSIS 4 0.0006
261 PERIPHERAL VASCULAR DISORDER 3 0.0006
262 CARDIAC MURMUR 5 0.0006
263 LABORATORY TEST ABNORMAL 17 0.0006
264 PAIN 353 0.0006
265 HYPOMAGNESAEMIA 8 0.0006
266 VIRAL INFECTION 19 0.0006
267 EOSINOPHILIA 10 0.0006
268 SERUM FERRITIN INCREASED 3 0.0006
269 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
270 LYMPHOCYTE COUNT DECREASED 10 0.0006
271 THERMAL BURN 4 0.0006
272 DIVERTICULUM 4 0.0006
273 GINGIVITIS 3 0.0006
274 PAIN IN EXTREMITY 163 0.0006
275 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
276 CHEST PAIN 102 0.0006
277 BONE DISORDER 10 0.0005
278 JAW DISORDER 3 0.0005
279 NONSPECIFIC REACTION 3 0.0005
280 GASTROINTESTINAL PAIN 6 0.0005
281 ROTATOR CUFF SYNDROME 7 0.0005
282 INCREASED TENDENCY TO BRUISE 5 0.0005
283 ALCOHOL USE 2 0.0005
284 MUCOSAL INFLAMMATION 14 0.0005
285 IMMUNE SYSTEM DISORDER 7 0.0005
286 FLATULENCE 30 0.0005
287 PERONEAL NERVE PALSY 3 0.0005
288 NEUROPATHY PERIPHERAL 50 0.0005
289 HYPERTHERMIA 4 0.0005
290 DRUG DISPENSING ERROR 8 0.0005
291 SKIN ATROPHY 3 0.0005
292 HYPOKALAEMIA 24 0.0005
293 DEVICE RELATED INFECTION 8 0.0005
294 HYPERCHOLESTEROLAEMIA 5 0.0005
295 ABDOMINAL DISTENSION 54 0.0005
296 PRODUCT TASTE ABNORMAL 7 0.0005
297 MUSCULOSKELETAL CHEST PAIN 8 0.0005
298 EYE PAIN 29 0.0005
299 DRUG TOXICITY 7 0.0005
300 FEBRILE NEUTROPENIA 34 0.0005
301 SPINAL PAIN 6 0.0005
302 PHARYNGEAL SWELLING 5 0.0005
303 MULTIPLE ALLERGIES 4 0.0005
304 URINE ODOUR ABNORMAL 3 0.0005
305 PERIPHERAL COLDNESS 7 0.0005
306 ENERGY INCREASED 3 0.0005
307 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
308 SINUS DISORDER 10 0.0005
309 ANAPHYLACTIC SHOCK 13 0.0005
310 ORAL DISCOMFORT 7 0.0005
311 CHILLS 59 0.0005
312 SCIATICA 8 0.0005
313 BLOOD DISORDER 4 0.0005
314 NEUTROPHIL COUNT INCREASED 5 0.0005
315 INITIAL INSOMNIA 5 0.0005
316 PIGMENTATION DISORDER 3 0.0005
317 MYELODYSPLASTIC SYNDROME 7 0.0005
318 INFUSION SITE EXTRAVASATION 3 0.0005
319 LIVER FUNCTION TEST ABNORMAL 14 0.0005
320 INFUSION SITE SWELLING 3 0.0005
321 CEREBRAL HAEMORRHAGE 17 0.0005
322 INFUSION SITE ERYTHEMA 4 0.0005
323 ABDOMINAL PAIN 110 0.0005
324 BUNDLE BRANCH BLOCK LEFT 2 0.0005
325 SCREAMING 3 0.0005
326 AORTIC VALVE INCOMPETENCE 2 0.0005
327 INFLUENZA 52 0.0005
328 ILLNESS 48 0.0005
329 ABNORMAL SENSATION IN EYE 2 0.0005
330 BLOOD MAGNESIUM DECREASED 4 0.0005
331 HIATUS HERNIA 6 0.0005
332 EAR PAIN 9 0.0005
333 CHAPPED LIPS 2 0.0005
334 SURGERY 27 0.0005
335 PLATELET COUNT INCREASED 6 0.0005
336 HAEMOGLOBIN DECREASED 47 0.0005
337 PRODUCT PREPARATION ISSUE 3 0.0005
338 WOUND INFECTION 5 0.0005
339 ORAL CANDIDIASIS 6 0.0005
340 GROIN PAIN 4 0.0005
341 DENTAL CARIES 5 0.0005
342 STEVENS-JOHNSON SYNDROME 10 0.0004
343 WRONG DRUG ADMINISTERED 4 0.0004
344 POST-TRAUMATIC STRESS DISORDER 3 0.0004
345 NAUSEA 354 0.0004
346 NEPHROPATHY TOXIC 5 0.0004
347 PRODUCT ADMINISTRATION ERROR 9 0.0004
348 HEAVY MENSTRUAL BLEEDING 4 0.0004
349 SINUS CONGESTION 6 0.0004
350 FEEDING DISORDER 9 0.0004
351 PLEURAL EFFUSION 27 0.0004
352 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
353 ASCITES 13 0.0004
354 PRODUCT LABEL ISSUE 3 0.0004
355 MITRAL VALVE INCOMPETENCE 5 0.0004
356 BODY TEMPERATURE INCREASED 9 0.0004
357 HEADACHE 275 0.0004
358 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 21 0.0004
359 ONYCHOCLASIS 3 0.0004
360 PALPITATIONS 51 0.0004
361 JOINT EFFUSION 3 0.0004
362 GASTRIC HAEMORRHAGE 5 0.0004
363 NERVE COMPRESSION 4 0.0004
364 HEPATIC FAILURE 13 0.0004
365 ARTHRITIS INFECTIVE 2 0.0004
366 MASS 6 0.0004
367 DEHYDRATION 57 0.0004
368 DIARRHOEA 275 0.0004
369 PHOTOSENSITIVITY REACTION 7 0.0004
370 COLITIS MICROSCOPIC 2 0.0004
371 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
372 IMPAIRED WORK ABILITY 9 0.0004
373 COAGULOPATHY 7 0.0004
374 PNEUMONIA 136 0.0004
375 JOINT STIFFNESS 11 0.0004
376 FAECES SOFT 3 0.0004
377 GASTROENTERITIS 6 0.0004
378 AUTOIMMUNE DISORDER 4 0.0004
379 PYREXIA 142 0.0004
380 CHEST DISCOMFORT 42 0.0004
381 HAEMORRHOIDS 8 0.0004
382 LUNG DISORDER 20 0.0004
383 LIVER INJURY 10 0.0004
384 BLOOD BILIRUBIN INCREASED 11 0.0004
385 CARDIOMYOPATHY 6 0.0004
386 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
387 PHARYNGITIS 5 0.0004
388 CYST 5 0.0004
389 THROMBOCYTOPENIA 45 0.0004
390 RESPIRATORY DISORDER 12 0.0004
391 SALIVARY HYPERSECRETION 4 0.0004
392 PREGNANCY 8 0.0004
393 HYPOXIA 14 0.0004
394 TENDON PAIN 3 0.0004
395 COLITIS 15 0.0004
396 FEELING COLD 11 0.0004
397 MUSCLE ATROPHY 5 0.0004
398 AORTIC ANEURYSM 3 0.0004
399 HAEMODYNAMIC INSTABILITY 3 0.0004
400 BONE MARROW FAILURE 8 0.0004
401 ACIDOSIS 3 0.0004
402 THIRST 7 0.0004
403 THYROID DISORDER 6 0.0004
404 CACHEXIA 2 0.0004
405 CEREBRAL ISCHAEMIA 2 0.0004
406 PAIN IN JAW 11 0.0004
407 CONCUSSION 3 0.0004
408 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
409 OSTEOMYELITIS 7 0.0004
410 ARTHRALGIA 160 0.0004
411 PLATELET COUNT DECREASED 41 0.0004
412 RESPIRATORY TRACT INFECTION 10 0.0004
413 POLLAKIURIA 16 0.0004
414 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
415 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
416 DRY MOUTH 31 0.0004
417 TOOTH INFECTION 5 0.0004
418 SCRATCH 4 0.0004
419 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
420 VOMITING 178 0.0004
421 FURUNCLE 3 0.0004
422 BLOOD ALBUMIN DECREASED 3 0.0004
423 RENAL CYST 3 0.0004
424 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
425 SEPSIS 42 0.0004
426 HEPATIC STEATOSIS 7 0.0004
427 BREAST PAIN 4 0.0004
428 TRANSPLANT REJECTION 3 0.0004
429 HAIR TEXTURE ABNORMAL 5 0.0004
430 OXYGEN SATURATION DECREASED 21 0.0004
431 UTERINE CANCER 3 0.0004
432 BREAST CANCER METASTATIC 4 0.0004
433 ANAEMIA 71 0.0004
434 BRUXISM 2 0.0004
435 MUSCLE DISORDER 3 0.0004
436 TINNITUS 17 0.0004
437 CHEILITIS 2 0.0004
438 BLOOD POTASSIUM INCREASED 6 0.0004
439 POST PROCEDURAL INFECTION 3 0.0004
440 MUSCULOSKELETAL DISORDER 7 0.0004
441 SEPTIC SHOCK 16 0.0004
442 ASPHYXIA 3 0.0004
443 MIGRAINE 35 0.0004
444 GINGIVAL BLEEDING 5 0.0004
445 ABNORMAL FAECES 3 0.0004
446 CHOLELITHIASIS 12 0.0004
447 HICCUPS 3 0.0004
448 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
449 ASTHENOPIA 2 0.0004
450 OSTEONECROSIS OF JAW 9 0.0004
451 DEAFNESS UNILATERAL 2 0.0004
452 SPINAL COMPRESSION FRACTURE 3 0.0004
453 MUSCULOSKELETAL PAIN 19 0.0004
454 EPISTAXIS 27 0.0004
455 HYPOAESTHESIA 54 0.0004
456 TRANSAMINASES INCREASED 8 0.0004
457 SKIN DISORDER 12 0.0004
458 WRONG TECHNIQUE IN DRUG USAGE PROCESS 13 0.0004
459 ORAL PAIN 8 0.0004
460 GASTROINTESTINAL DISORDER 32 0.0004
461 BLOOD TEST ABNORMAL 5 0.0004
462 BLOOD CALCIUM DECREASED 4 0.0004
463 CANDIDA INFECTION 6 0.0004
464 CHROMATURIA 8 0.0004
465 CHOLECYSTITIS ACUTE 2 0.0004
466 HYPOPHAGIA 9 0.0004
467 OEDEMA 19 0.0003
468 EYE SWELLING 13 0.0003
469 PSYCHOLOGICAL TRAUMA 3 0.0003
470 MUSCLE TWITCHING 8 0.0003
471 PARAESTHESIA ORAL 5 0.0003
472 INTESTINAL OBSTRUCTION 13 0.0003
473 CAESAREAN SECTION 4 0.0003
474 NAIL DISORDER 3 0.0003
475 RESPIRATORY FAILURE 25 0.0003
476 GASTRITIS 9 0.0003
477 SPINAL OSTEOARTHRITIS 3 0.0003
478 SEXUAL DYSFUNCTION 4 0.0003
479 PRODUCT PREPARATION ERROR 7 0.0003
480 COLD SWEAT 6 0.0003
481 OSTEOPOROSIS 14 0.0003
482 LUNG INFILTRATION 3 0.0003
483 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
484 PURPURA 3 0.0003
485 HEAD DISCOMFORT 6 0.0003
486 EAR INFECTION 9 0.0003
487 SKIN HAEMORRHAGE 5 0.0003
488 BLOOD IRON DECREASED 4 0.0003
489 CATARACT OPERATION 2 0.0003
490 COVID-19 59 0.0003
491 PULMONARY HYPERTENSION 7 0.0003
492 CONDITION AGGRAVATED 102 0.0003
493 MACULAR DEGENERATION 4 0.0003
494 JAUNDICE 9 0.0003
495 FREQUENT BOWEL MOVEMENTS 9 0.0003
496 HOT FLUSH 25 0.0003
497 LEUKOCYTOSIS 6 0.0003
498 PERIPHERAL SWELLING 51 0.0003
499 PALLOR 9 0.0003
500 NOCTURIA 4 0.0003
501 RETCHING 7 0.0003
502 PNEUMONIA BACTERIAL 3 0.0003
503 IRRITABLE BOWEL SYNDROME 7 0.0003
504 CARDIOMEGALY 4 0.0003
505 NECK PAIN 18 0.0003
506 LUNG INFECTION 5 0.0003
507 ERYTHEMA MULTIFORME 3 0.0003
508 HAIR COLOUR CHANGES 4 0.0003
509 TOOTH EXTRACTION 4 0.0003
510 BASAL CELL CARCINOMA 5 0.0003
511 SEIZURE 37 0.0003
512 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
513 LEUKOPENIA 16 0.0003
514 CYANOSIS 5 0.0003
515 INFECTION 46 0.0003
516 DYSPEPSIA 31 0.0003
517 RECALLED PRODUCT ADMINISTERED 3 0.0003
518 ULCER 5 0.0003
519 PRODUCTIVE COUGH 15 0.0003
520 BLOOD PRESSURE INCREASED 48 0.0003
521 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
522 HEPATITIS 8 0.0003
523 PRODUCT SUBSTITUTION ISSUE 18 0.0003
524 PARAESTHESIA 49 0.0003
525 NIGHT SWEATS 10 0.0003
526 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
527 ERUCTATION 6 0.0003
528 VITAMIN D DEFICIENCY 3 0.0003
529 BACK DISORDER 5 0.0003
530 NODULE 4 0.0003
531 RENAL FAILURE ACUTE 13 0.0003
532 RENAL TUBULAR NECROSIS 3 0.0003
533 DECREASED APPETITE 71 0.0003
534 METASTASES TO BONE 5 0.0003
535 WEIGHT INCREASED 68 0.0003
536 PULMONARY CONGESTION 4 0.0003
537 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
538 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
539 WEIGHT DECREASED 84 0.0003
540 CYTOMEGALOVIRUS INFECTION 5 0.0003
541 HYPOTONIA 3 0.0003
542 OVARIAN CYST 3 0.0003
543 MYALGIA 51 0.0003
544 DYSURIA 11 0.0003
545 APHASIA 9 0.0003
546 TOXIC SKIN ERUPTION 3 0.0003
547 FULL BLOOD COUNT DECREASED 6 0.0003
548 PAIN OF SKIN 8 0.0003
549 LETHARGY 17 0.0003
550 DRY THROAT 3 0.0003
551 HEPATIC ENZYME INCREASED 20 0.0003
552 URINARY TRACT INFECTION 50 0.0003
553 EUPHORIC MOOD 3 0.0003
554 RIB FRACTURE 6 0.0003
555 SKIN LESION 8 0.0003
556 UNEVALUABLE EVENT 22 0.0003
557 POOR VENOUS ACCESS 3 0.0003
558 DROOLING 2 0.0003
559 LOCALISED INFECTION 7 0.0003
560 VENTRICULAR EXTRASYSTOLES 3 0.0003
561 MUSCLE SPASMS 53 0.0003
562 NEURALGIA 7 0.0003
563 ATRIAL FIBRILLATION 28 0.0003
564 PETECHIAE 3 0.0003
565 ROAD TRAFFIC ACCIDENT 12 0.0003
566 COORDINATION ABNORMAL 4 0.0003
567 INFUSION RELATED REACTION 19 0.0003
568 LOCAL SWELLING 5 0.0003
569 PRODUCT ODOUR ABNORMAL 3 0.0003
570 GASTROOESOPHAGEAL REFLUX DISEASE 23 0.0003
571 DEFAECATION URGENCY 2 0.0003
572 FLUSHING 29 0.0003
573 FATIGUE 222 0.0003
574 METASTASES TO LIVER 5 0.0003
575 RENAL PAIN 3 0.0003
576 SINUSITIS 29 0.0003
577 CYSTITIS 9 0.0003
578 DRUG ERUPTION 5 0.0003
579 DIALYSIS 4 0.0003
580 HYPOTHYROIDISM 9 0.0003
581 JOINT INJURY 6 0.0003
582 PNEUMONIA ASPIRATION 7 0.0003
583 RENAL DISORDER 13 0.0003
584 DISCOMFORT 17 0.0003
585 PRURITUS 107 0.0003
586 DECREASED ACTIVITY 3 0.0003
587 INSOMNIA 74 0.0003
588 ABDOMINAL PAIN LOWER 7 0.0003
589 SWELLING FACE 18 0.0003
590 TOOTHACHE 5 0.0003
591 BACK INJURY 3 0.0003
592 BLOOD CREATININE INCREASED 18 0.0003
593 APATHY 4 0.0003
594 END STAGE RENAL DISEASE 5 0.0003
595 STAPHYLOCOCCAL INFECTION 9 0.0003
596 SKIN EXFOLIATION 23 0.0003
597 CEREBRAL DISORDER 2 0.0003
598 LIP SWELLING 9 0.0003
599 CONTUSION 26 0.0003
600 OROPHARYNGEAL PAIN 25 0.0003
601 BLINDNESS 11 0.0003
602 ARTHROPOD BITE 2 0.0003
603 TOOTH DISORDER 6 0.0003
604 NERVE INJURY 3 0.0003
605 HYPERTENSIVE CRISIS 3 0.0003
606 CONJUNCTIVITIS 5 0.0003
607 GAIT INABILITY 9 0.0003
608 GLOSSODYNIA 6 0.0003
609 THROAT IRRITATION 12 0.0003
610 BLISTER 15 0.0003
611 FEELING ABNORMAL 64 0.0003
612 FISTULA 3 0.0003
613 HEART RATE IRREGULAR 6 0.0003
614 DYSPNOEA EXERTIONAL 10 0.0003
615 HYPOAESTHESIA ORAL 4 0.0003
616 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
617 IMPAIRED DRIVING ABILITY 3 0.0003
618 STOMATITIS 16 0.0003
619 FOOT FRACTURE 5 0.0003
620 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
621 BLOOD URINE PRESENT 5 0.0003
622 INTENTIONAL PRODUCT USE ISSUE 23 0.0003
623 HEART RATE INCREASED 26 0.0003
624 INCREASED APPETITE 5 0.0003
625 DEEP VEIN THROMBOSIS 17 0.0003
626 DRUG PRESCRIBING ERROR 5 0.0003
627 METASTASES TO LUNG 3 0.0003
628 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
629 TREMOR 43 0.0003
630 LIMB DISCOMFORT 8 0.0003
631 ASTHENIA 97 0.0003
632 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
633 ORAL HERPES 5 0.0003
634 BONE PAIN 15 0.0003
635 RECTAL HAEMORRHAGE 11 0.0003
636 SKIN FISSURES 5 0.0003
637 DYSGEUSIA 19 0.0003
638 NASAL CONGESTION 15 0.0003
639 BRAIN FOG 4 0.0003
640 NASOPHARYNGITIS 47 0.0003
641 COVID-19 PNEUMONIA 3 0.0003
642 DIVERTICULITIS 7 0.0003
643 MENTAL STATUS CHANGES 7 0.0003
644 COMA 12 0.0003
645 INFLAMMATION 13 0.0003
646 CHOLECYSTITIS 3 0.0003
647 BLOOD PRESSURE ABNORMAL 5 0.0003
648 ACCIDENT 3 0.0003
649 ATRIAL FLUTTER 2 0.0003
650 GENERAL PHYSICAL HEALTH DETERIORATION 29 0.0003
651 WRIST FRACTURE 3 0.0003
652 BLOOD PRESSURE FLUCTUATION 6 0.0002
653 ALOPECIA 49 0.0002
654 DRUG INTOLERANCE 24 0.0002
655 MENTAL IMPAIRMENT 6 0.0002
656 RASH 107 0.0002
657 DECUBITUS ULCER 2 0.0002
658 URTICARIA 41 0.0002
659 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
660 SPINAL OPERATION 3 0.0002
661 INJECTION SITE EXTRAVASATION 3 0.0002
662 ABASIA 6 0.0002
663 PANCREATIC CARCINOMA 7 0.0002
664 ARTHRITIS 19 0.0002
665 ILEUS 3 0.0002
666 HEPATIC FUNCTION ABNORMAL 9 0.0002
667 AGEUSIA 6 0.0002
668 JOINT SWELLING 29 0.0002
669 FUNGAL INFECTION 8 0.0002
670 INTENTIONAL PRODUCT MISUSE 21 0.0002
671 SECRETION DISCHARGE 3 0.0002
672 DYSPHONIA 14 0.0002
673 KNEE ARTHROPLASTY 5 0.0002
674 MOUTH ULCERATION 5 0.0002
675 THROMBOSIS 19 0.0002
676 SWELLING 22 0.0002
677 MALAISE 103 0.0002
678 HAEMATURIA 8 0.0002
679 VISION BLURRED 32 0.0002
680 ANOREXIA 3 0.0002
681 CARDIAC OPERATION 2 0.0002
682 MUSCULOSKELETAL DISCOMFORT 4 0.0002
683 POOR QUALITY SLEEP 5 0.0002
684 LACRIMATION INCREASED 7 0.0002
685 BALANCE DISORDER 20 0.0002
686 PLASMA CELL MYELOMA 9 0.0002
687 BRONCHITIS 17 0.0002
688 BLOOD GLUCOSE DECREASED 11 0.0002
689 MUSCULAR WEAKNESS 26 0.0002
690 FEELING HOT 14 0.0002
691 COUGH 64 0.0002
692 BURNING SENSATION 16 0.0002
693 DRUG ADMINISTRATION ERROR 7 0.0002
694 ALANINE AMINOTRANSFERASE INCREASED 14 0.0002
695 INTERSTITIAL LUNG DISEASE 11 0.0002
696 SARS-COV-2 TEST POSITIVE 3 0.0002
697 SLEEP DISORDER 16 0.0002
698 ADVERSE REACTION 3 0.0002
699 LYMPHADENOPATHY 8 0.0002
700 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
701 LIVER DISORDER 10 0.0002
702 COLITIS ULCERATIVE 10 0.0002
703 QUALITY OF LIFE DECREASED 3 0.0002
704 GOUT 4 0.0002
705 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
706 THROAT TIGHTNESS 6 0.0002
707 RASH PRURITIC 12 0.0002
708 HEAD INJURY 7 0.0002
709 PULMONARY EMBOLISM 21 0.0002
710 LIMB INJURY 6 0.0002
711 NEUTROPHIL COUNT DECREASED 9 0.0002
712 DRY EYE 11 0.0002
713 IMPAIRED GASTRIC EMPTYING 3 0.0002
714 GAIT DISTURBANCE 42 0.0002
715 DYSPNOEA 124 0.0002
716 RESTLESSNESS 8 0.0002
717 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
718 HAEMATOCHEZIA 12 0.0002
719 SHOCK 5 0.0002
720 PERICARDIAL EFFUSION 5 0.0002
721 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
722 THINKING ABNORMAL 4 0.0002
723 DIZZINESS 107 0.0002
724 MIDDLE INSOMNIA 4 0.0002
725 DIARRHOEA HAEMORRHAGIC 2 0.0002
726 VERTIGO 13 0.0002
727 DEVICE OCCLUSION 3 0.0002
728 EYE DISORDER 7 0.0002
729 ARTERIOSCLEROSIS 2 0.0002
730 OSTEOARTHRITIS 9 0.0002
731 HYPOCALCAEMIA 4 0.0002
732 SINUS TACHYCARDIA 3 0.0002
733 EXPIRED PRODUCT ADMINISTERED 7 0.0002
734 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
735 PROTEINURIA 4 0.0002
736 INCORRECT DOSE ADMINISTERED 48 0.0002
737 SLEEP APNOEA SYNDROME 4 0.0002
738 SUBDURAL HAEMATOMA 3 0.0002
739 HYPERSOMNIA 6 0.0002
740 RASH ERYTHEMATOUS 10 0.0002
741 POST PROCEDURAL COMPLICATION 4 0.0002
742 LOWER LIMB FRACTURE 4 0.0002
743 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
744 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
745 CARDIAC ARREST 17 0.0002
746 DYSSTASIA 6 0.0002
747 HYPOTENSION 41 0.0002
748 ERYTHEMA 42 0.0002
749 MULTIPLE SCLEROSIS RELAPSE 14 0.0002
750 GASTRIC DISORDER 7 0.0002
751 SOMNOLENCE 41 0.0002
752 TACHYCARDIA 18 0.0002
753 URINARY INCONTINENCE 6 0.0002
754 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
755 NIGHTMARE 7 0.0002
756 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
757 BLADDER DISORDER 2 0.0002
758 COLON CANCER 3 0.0002
759 IMMUNODEFICIENCY 3 0.0002
760 RHINORRHOEA 13 0.0002
761 BLOOD POTASSIUM DECREASED 6 0.0002
762 HEART RATE DECREASED 7 0.0002
763 PREMATURE BABY 6 0.0002
764 HAEMATEMESIS 5 0.0002
765 PRODUCT USE ISSUE 37 0.0002
766 PANCYTOPENIA 11 0.0002
767 FLUID RETENTION 10 0.0002
768 ACUTE KIDNEY INJURY 30 0.0002
769 SKIN DISCOLOURATION 9 0.0002
770 HYPONATRAEMIA 11 0.0002
771 EMOTIONAL DISORDER 6 0.0002
772 INFLUENZA LIKE ILLNESS 16 0.0002
773 HYPERHIDROSIS 25 0.0002
774 UNRESPONSIVE TO STIMULI 5 0.0002
775 DEPRESSION 44 0.0002
776 C-REACTIVE PROTEIN INCREASED 7 0.0002
777 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
778 DERMATITIS 4 0.0002
779 DYSPHAGIA 18 0.0002
780 BRADYCARDIA 10 0.0002
781 EATING DISORDER 4 0.0002
782 METABOLIC ACIDOSIS 6 0.0002
783 SENSORY DISTURBANCE 3 0.0002
784 DISEASE PROGRESSION 22 0.0002
785 MUSCLE TIGHTNESS 3 0.0002
786 PRURITUS GENERALISED 4 0.0002
787 AMNESIA 12 0.0002
788 PRODUCT DISPENSING ERROR 4 0.0002
789 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
790 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 33 0.0002
791 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
792 NO ADVERSE EVENT 33 0.0002
793 PROCEDURAL PAIN 5 0.0002
794 DRY SKIN 24 0.0002
795 HEPATOTOXICITY 4 0.0002
796 LOSS OF CONSCIOUSNESS 23 0.0002
797 HYPERTENSION 38 0.0002
798 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
799 ANGER 6 0.0002
800 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
801 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
802 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
803 NEUTROPENIA 24 0.0002
804 ANXIETY 50 0.0002
805 DERMATITIS CONTACT 2 0.0002
806 SCAR 3 0.0002
807 OFF LABEL USE 153 0.0002
808 MEMORY IMPAIRMENT 24 0.0002
809 PARANOIA 3 0.0002
810 EYE IRRITATION 10 0.0002
811 NEOPLASM PROGRESSION 6 0.0002
812 ECZEMA 9 0.0002
813 RASH MACULAR 6 0.0002
814 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
815 SYRINGE ISSUE 3 0.0002
816 COGNITIVE DISORDER 8 0.0002
817 OCULAR HYPERAEMIA 8 0.0002
818 FALL 56 0.0002
819 GALLBLADDER DISORDER 3 0.0002
820 CATARACT 10 0.0002
821 GASTROINTESTINAL HAEMORRHAGE 14 0.0002
822 CONFUSIONAL STATE 27 0.0002
823 MOBILITY DECREASED 12 0.0002
824 DISTURBANCE IN ATTENTION 9 0.0002
825 BLOOD PRESSURE DECREASED 11 0.0002
826 BURSITIS 2 0.0002
827 ADRENAL INSUFFICIENCY 2 0.0002
828 PANIC ATTACK 6 0.0002
829 ILL-DEFINED DISORDER 10 0.0002
830 OEDEMA PERIPHERAL 20 0.0002
831 ARTHROPATHY 9 0.0002
832 FEMUR FRACTURE 5 0.0002
833 AGRANULOCYTOSIS 3 0.0002
834 NERVOUS SYSTEM DISORDER 5 0.0002
835 SWOLLEN TONGUE 5 0.0002
836 DERMATITIS ALLERGIC 2 0.0002
837 RENAL FAILURE 21 0.0002
838 GASTRIC ULCER 3 0.0002
839 FEELING JITTERY 3 0.0002
840 MOOD SWINGS 5 0.0002
841 PULMONARY FIBROSIS 3 0.0002
842 PULMONARY OEDEMA 7 0.0002
843 HYPERSENSITIVITY 29 0.0002
844 ACUTE RESPIRATORY FAILURE 3 0.0002
845 ERECTILE DYSFUNCTION 4 0.0002
846 HIP FRACTURE 5 0.0002
847 HERNIA 3 0.0002
848 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
849 CHOKING 3 0.0002
850 NERVOUSNESS 8 0.0002
851 DEAFNESS 4 0.0002
852 KIDNEY INFECTION 3 0.0002
853 SPEECH DISORDER 8 0.0002
854 IMPAIRED HEALING 5 0.0002
855 ANHEDONIA 4 0.0002
856 DISORIENTATION 6 0.0002
857 DEPRESSED MOOD 8 0.0002
858 HAEMATOCRIT DECREASED 3 0.0002
859 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
860 URINARY RETENTION 5 0.0001
861 PRODUCT PHYSICAL ISSUE 3 0.0001
862 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
863 MULTIPLE SCLEROSIS 7 0.0001
864 RESPIRATORY ARREST 4 0.0001
865 RESPIRATORY DISTRESS 4 0.0001
866 ABNORMAL DREAMS 4 0.0001
867 RHABDOMYOLYSIS 6 0.0001
868 HAEMOPTYSIS 4 0.0001
869 APHONIA 2 0.0001
870 CARPAL TUNNEL SYNDROME 2 0.0001
871 SUICIDAL IDEATION 13 0.0001
872 HYPOACUSIS 6 0.0001
873 SKIN CANCER 3 0.0001
874 CELLULITIS 7 0.0001
875 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
876 FAECES DISCOLOURED 3 0.0001
877 ANOSMIA 2 0.0001
878 BLOOD GLUCOSE INCREASED 26 0.0001
879 INJECTION SITE BRUISING 11 0.0001
880 MENTAL DISORDER 6 0.0001
881 HYPERGLYCAEMIA 5 0.0001
882 CARDIAC FAILURE CONGESTIVE 11 0.0001
883 RASH PAPULAR 3 0.0001
884 SNEEZING 3 0.0001
885 PANCREATITIS ACUTE 3 0.0001
886 BONE LOSS 2 0.0001
887 IRRITABILITY 8 0.0001
888 DYSARTHRIA 5 0.0001
889 ASTHMA 15 0.0001
890 PANCREATITIS 7 0.0001
891 CHRONIC KIDNEY DISEASE 10 0.0001
892 DIABETES MELLITUS 10 0.0001
893 VISUAL IMPAIRMENT 16 0.0001
894 EXPOSURE DURING PREGNANCY 8 0.0001
895 INJURY 9 0.0001
896 DEATH 110 0.0001
897 ANAPHYLACTIC REACTION 7 0.0001
898 DISEASE RECURRENCE 6 0.0001
899 MUSCULOSKELETAL STIFFNESS 11 0.0001
900 MOVEMENT DISORDER 4 0.0001
901 CARDIAC FAILURE 10 0.0001
902 HAEMORRHAGE 13 0.0001
903 HYPOGLYCAEMIA 6 0.0001
904 LACTIC ACIDOSIS 4 0.0001
905 FIBROMYALGIA 3 0.0001
906 PRESYNCOPE 3 0.0001
907 DYSKINESIA 5 0.0001
908 CONVULSION 7 0.0001
909 SYNCOPE 12 0.0001
910 WITHDRAWAL SYNDROME 5 0.0001
911 ACNE 9 0.0001
912 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
913 PRODUCT COMPLAINT 3 0.0001
914 WHEEZING 7 0.0001
915 DRUG INEFFECTIVE 155 0.0001
916 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
917 AMENORRHOEA 2 0.0001
918 HYPERKALAEMIA 4 0.0001
919 DERMATITIS ATOPIC 6 0.0001
920 DRUG INTERACTION 18 0.0001
921 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
922 MENSTRUATION IRREGULAR 3 0.0001
923 SKIN BURNING SENSATION 8 0.0001
924 FEAR 3 0.0001
925 THERAPY NON-RESPONDER 5 0.0001
926 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
927 CRYING 4 0.0001
928 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
929 ACCIDENTAL OVERDOSE 4 0.0001
930 SKIN IRRITATION 5 0.0001
931 NEPHROLITHIASIS 5 0.0001
932 AGITATION 8 0.0001
933 BLOOD GLUCOSE ABNORMAL 2 0.0001
934 DEMENTIA 3 0.0001
935 WOUND 3 0.0001
936 RENAL IMPAIRMENT 9 0.0001
937 CARDIAC DISORDER 10 0.0001
938 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
939 PRODUCT USE IN UNAPPROVED INDICATION 26 0.0001
940 ANGINA PECTORIS 3 0.0001
941 HERPES ZOSTER 6 0.0001
942 INJECTION SITE SWELLING 8 0.0001
943 PRODUCT QUALITY ISSUE 14 0.0001
944 CEREBROVASCULAR ACCIDENT 17 0.0001
945 INJECTION SITE HAEMORRHAGE 8 0.0001
946 EXTRA DOSE ADMINISTERED 4 0.0001
947 PSORIATIC ARTHROPATHY 4 0.0001
948 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
949 EPILEPSY 3 0.0001
950 RHEUMATOID ARTHRITIS 11 0.0001
951 BONE DENSITY DECREASED 3 0.0001
952 DRUG-INDUCED LIVER INJURY 3 0.0001
953 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19 0.0001
954 MYOCARDIAL INFARCTION 16 0.0001
955 NEOPLASM MALIGNANT 6 0.0001
956 DELIRIUM 3 0.0001
957 BLOOD CHOLESTEROL INCREASED 4 0.0001
958 ARRHYTHMIA 4 0.0001
959 PSORIASIS 11 0.0001
960 THERAPEUTIC RESPONSE DECREASED 5 0.0001
961 CEREBRAL INFARCTION 2 0.0001
962 INJECTION SITE ERYTHEMA 10 0.0001
963 AGGRESSION 4 0.0001
964 HALLUCINATION 6 0.0001
965 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
966 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
967 DIPLOPIA 2 0.0001
968 CARDIO-RESPIRATORY ARREST 3 0.0001
969 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
970 DEVICE DISLOCATION 3 0.0001
971 ACUTE MYOCARDIAL INFARCTION 2 0.0001
972 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
973 CORONARY ARTERY DISEASE 2 0.0001
974 OVERDOSE 14 0.0001
975 INJECTION SITE PAIN 19 0.0001
976 INJECTION SITE PRURITUS 4 0.0001
977 INJECTION SITE REACTION 4 0.0001
978 EMOTIONAL DISTRESS 7 0.0001
979 SUICIDE ATTEMPT 3 0.0000
980 DEVICE BREAKAGE 2 0.0000
981 ANGIOEDEMA 2 0.0000
982 DEVICE ISSUE 4 0.0000
983 PROSTATE CANCER 3 0.0000
984 DEPENDENCE 2 0.0000
985 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
986 TREATMENT FAILURE 3 0.0000
987 DRUG ABUSE 3 0.0000
988 TOXICITY TO VARIOUS AGENTS 6 0.0000
989 BREAST CANCER 3 0.0000
990 DEVICE DIFFICULT TO USE 2 0.0000
991 DEVICE MALFUNCTION 2 0.0000
992 DRUG WITHDRAWAL SYNDROME 2 0.0000
993 DRUG DEPENDENCE 2 0.0000